Clinical Trial Update: Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 safety study of pertuzumab in combination with trastuzumab and docetaxel in Indian participants with breast cancer has completed; results posted in 2019…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2019-10-29